Superinfection of chicken embryo fibroblasts transformed by the defective Bryan strain of Rous sarcoma virus (BH-RSV) with two different reticuloendotheliosis viruses (REVs), REV strain T (REV-T) or spleen necrosis virus (SNV), resulted in the production of infectious sarcoma virus pseudotypes. These pseudotypes were neutralized by antiserum prepared against SNV and were unable to infect chicken cells preinfected with either REV-T or SNV. These results suggest that defective BH-RSV is able to use the glycoprotein from REV to form infectious pseudotypes. On the other hand, neither REV-T nor SNV was able to supply a functional reverse transcriptase to the polymerase-negative mutant BH-RSVa, nor was REV-T or SNV able to complement the defect in the internal protein gene of the temperature-sensitive avian sarcoma virus mutant NY45.
The Bryan high-titer strain of Rous sarcoma virus (BH-RSV) is an avian sarcoma virus (ASV) unable to direct synthesis of its envelope glycoprotein (8) . High titers of infectious pseudotypes are readily obtained by infecting chicken cells producing an endogenous glycoprotein, the chicken helper factor (chf-positive cells), or by superinfecting BH-RSV-transformed cells with an avian leukosis virus (ALV) (9, 10) . Host range and antigenicity of the pseudotype are those of the helper virus.
Spleen necrosis virus (SNV) and reticuloendotheliosis virus (strain T) (REV-T) are members of a second species of avian RNA viruses, the REVs, which apparently are distinct from the avian leukosis-sarcoma viruses (ALSVs) (4, 15, 19) . The REV species includes, besides SNV and REV-T, duck infectious anemia virus and chicken syncytial virus (24) . (REV is the name both of the species and of one of the members of the species.) Within the species the differences among the four members are primarily antigenic and in their pathogenicity for different avian species (24) . Both the ALSVs and REVs have type C morphology, 60 to 70S RNA, and a virion-associated RNA-dependent DNA polymerase and replicate through a DNA intermediate (2, 4, 16, 23) . However, they share little (<5%) homology between their RNAs, are serologically distinct, have different protein compositions, and have been reported to have no biological interaction, including phenotypic mixing (4, 15, 19, 20) . We have reexamined the question of complementation between the ALSVs and the REVs in light of the recent observation that BH-RSV is able to utilize the envelope glycoprotein of other non-ALSVs, the pheasant viruses and vesicular stomatitis virus (VSV), to make infectious pseudotypes (3, 11, 12, 27) .
In this paper we report that SNV and REV-T can complement BH-RSV for the envelope glycoprotein although at a much lower efficiency than an ALV. We were unable to detect any complementation by SNV of an ASV defective for the viral polymerase BH-RSVa (6, 7, 25) or of a mutant believed to have a temperaturesensitive defect in the gene for the viral internal proteins (NY45; C. Metroka, S. Kawai, and H. Hanafusa, manuscript in preparation).
MATERIALS AND METHODS Cells and viruses. Chicken embryo cells used in these studies were obtained from fertile eggs (SPA-FAS, Inc., Norwich, Conn.) and were positive for group-specific (gs) antigen and chicken helper factor (chf) expression (gs+ chf+; C/E) unless otherwise specified (13) . Chicken cells transformed by BH-RSV(-) were prepared by infection in the presence of UV-treated Sendai virus as described by Hanafusa et al. (14) . Stocks of BH-RSV(-) were grown on gs-chf-chick cells. Cultures of BH-RSVa(polymerase negative)-transformed chicken cells were grown from individual soft agar colonies as follows. Secondary cultures of chicken embryo cells (7 
RESULTS
Complementation by REV. To test whether an REV could complement the defective BH-RSV for glycoprotein, chicken embryo fibroblasts transformed by BH-RSV(-) were superinfected with either RAV-1, SNV, or REV-T. At 4 days after infection, the culture fluids were harvested and assayed on chicken cells for the presence of infectious sarcoma virus. Table 1 shows that the SNV-and REV-T-superinfected cells produced between 102 and 104 FFU of infectious sarcoma virus per ml. This is 10-2 to 10-3 of the titers of BH-RSV(RAV-1) produced from the same BH-RSV-transformed cells when superinfected with RAV-1. Approximately equal virus titers were obtained regardless of whether the cells used to produce the pseudotypes were of the gs-chf-or gs+ chf+ phenotype. We have called these pseudotypes BH-RSV(SNV) and BH-RSV(REV-T), respectively.
Using multiplicities of infection in the range from 0.1 to 10 for the superinfecting SNV and REV-T did not increase the REV pseudotype titers above 104. Therefore, the relatively low yields were probably not due to incomplete infection of the culture by helper virus. In addition, titers of REV pseudotypes were not increased by subculturing REV-superinfected RSV-transformed cells.
As with many RSVs, the addition of DEAEdextran (final concentration, 5 ,g/ml) to the assay plates increased the number of foci formed. For BH-RSV(REV-T) and BH-RSV(SNV), the increase was about 10-fold over assay plates inoculated without DEAE-dextran. This agrees with a preliminary observation that DEAEdextran increased the apparent titer of SNV by about 10-fold when stocks of the virus were titered by end point dilution (data not shown). In these studies both RAV-1 and SNV pseudotypes were detected at 16 h postinfection. The titer of BH-RSV(SNV) plateaued at a relatively low level (103 to 2 x 103 FFU/ml) after 48 h and was not increased by transferring the culture (Fig. 1) . The kinetics are virtually identical to those from earlier studies with RAV-1 (5) .
Interference and neutralization of BH-RSV(REV) pseudotypes. If the REV supplied the defective BH-RSV(-) with envelope glycoprotein, cells preinfected with REV-T or SNV should be resistant to infection with BH- chicken cells were preinfected with either RAV-1, REV-T, SNV, or APV. After three transfers to insure that all cells in each culture were infected, the cultures were challenged with BH-RSV(RAV-1), BH-RSV(REV-T), BH-RSV(SNV), or BH-RSV(APV). The pattern of interference is shown in Table 2 . As expected, preinfection with each ofthe four helper viruses resulted in interference with the homologous pseudotype. Both SNV and REV-T prevented infection by BH-RSV(REV-T) and BH-RSV(SNV). This was expected since antisera against SNV will also neutralize REV-T, and vice versa, with the homologous reactions being stronger (24) .
RSV(REV-T) or BH-RSV(SNV
The nature of the BH-RSV(SNV) and BH-RSV(REV-T) glycoproteins was further tested by preincubating samples of BH-RSV(RAV-1), BH-RSV(SNV), and BH-RSV(REV-T) with chicken sera containing antibodies against RAV-1, RAV-2, or SNV. The anti-SNV serum reduced the titer of BH-RSV(SNV) and BH-RSV(REV-T) by a factor of 10-3 at dilutions of 1:400 and 1:200, respectively. Neither the anti-RAV-1 nor anti-RAV-2 sera were effective against the BH-RSV(REV) pseudotypes at dilutions as low as 1:10.
Inability of REV and SNV to complement for RSV polymerase. Although the REV are able to complement ASV for the envelope glycoprotein, they cannot activate production of infectious sarcoma virus from cultures transformed by the polymerase-negative mutant BH-RSVa. These cultures produce noninfectious particles lacking the viral polymerase (6, 7, 25) . After superinfection with either RAV-1, SNV, or REV-T, culture fluid was harvested at 4 days postinfection. The culture fluid was assayed for both infectious sarcoma virus and RNA-dependent DNA polymerase activity (Table 3). RAV-1 was able to complement BHRSVa for polymerase, whereas SNV and REV-T (data not shown) were not. That a productive SNV infection had been established in BHRSVa-infected cells was confirmed by the appearance in the culture fluid of RNA-dependent DNA polymerase activity of approximately the same magnitude as with RAV-1-superinfected cultures ( Table 2) .
Lack of complementation by REV for sarcoma virus internal proteins. Finally, SNV and REV-T were tested for their ability to complement an RSV mutant, NY45, with a temperature-sensitive defect believed to be in the gene for the internal proteins. Titers of NY45 grown at 41'C are reduced by about 10-3 as compared with virus grown at 370C (C. Metroka, S. Kawai, and H. Hanafusa, manuscript in preparation). In this experiment RAV-2, a subgroup B leukosis virus, was used as the helper virus Table 4 . RAV-2 readily increased the titers of NY45 grown at 410C to the levels produced at the permissive temperature, 370C. However, titers of NY45 grown at 410C were not increased by growing the virus in cells preinfected with either SNV or REV-T. DISCUSSION The results presented in this paper are the first evidence for a biological interaction between two apparently distinct species of viruses, the REVs and the ASVs. BH-RSV, which is deficient in synthesis of the viral envelope glycoprotein, can utilize the glycoprotein of aTwo clones (a3 and a13) of polymerase-negative BH-RSV and one clone of the polymerase-positive BH-RSV (/3) were superinfected with RAV-1 or SNV. After 4 days the culture fluids were harvested and assayed for the presence of virus-associated RNA-dependent DNA polymerase activity and infectious sarcoma virus. Culture supernatants were assayed on chicken and quail cells for the presence of infectious transforming virus. Polymerase assays were performed as outlined in the text, using duplicate samples from 10 ml of culture fluid. (27) have reported that the formation of BH-RSV(VSV) pseudotypes is of the order of 102 less efficient than formation of BH-RSV(RAV-1) pseudotypes (27 (24) . It is probable that the attachment and penetration mechanisms in REV infection are similar to those involved in ALSV infections. Thus, preinfection with SNV or REV-T would be expected to block secondary infections by BH-RSV, whose envelope glycoprotein was that of SNV or REV-T.
Similarly, since antibodies to whole virus are primarily raised against the envelope glycoproteins, the fact that anti-SNV serum, but not anti-RAV-1 or anti-RAV-2 serum, neutralized BH-RSV(SNV) and BH-RSV(REV-T) suggests that, in fact, BH-RSV is able to utilize an "un-VOL. 22, 1977 on October 18, 2017 by guest http://jvi.asm.org/ Downloaded from related" virus glycoprotein to form an infectious particle.
We assume that the complementation we see upon superinfection with REV is due to the incorporation of REV glycoprotein in an otherwise envelope-deficient BH-RSV particle. We cannot, however, rule out the possibility that what we observe is instead the infrequent inclusion of a BH-RSV genome (or subunit) into an REV particle. The frequency of formation of BH-RSV(SNV) and BH-RSV(REV-T) [about 103 times less than BH-RSV(RAV-1) or about 1/ 50 to 100 cells per harvest interval] is of the same magnitude as the recovery of recombinants from some mixed infections of ALV-ASV, a process thought to be initiated by the inclusion of heterologous subunits within a single particle (28, 29) .
Despite the ability of SNV to complement the glycoprotein defect of BH-RSV, it was not able to complement BH-RSVa for the viral polymerase or NY45 for a temperature-sensitive internal protein gene(s). Although retrovirus RNAdependent DNA polymerases will readily copy heterologous 70S RNAs in vitro (i.e., purified murine leukemia virus polymerase will copy RSV 70S RNA and use tRNArP as the primer) (W. Haseltine, A. Panet, D. Smoler, D. Baltimore, G. Peters, F. Harada, and J. Dahlberg, manuscript in preparation), it is not known whether SNV polymerase is able to copy RSV 70S RNA in vivo. The inability of the a form of BH-RSV to utilize the SNV polymerase may be due to the lack of proper primer molecules, that is, the primer molecule normally used by SNV. Mizutani and Temin have postulated that an RNA polymerase found in SNV virions may be responsible for synthesis of an RNA primer on SNV 70S RNA prior to DNA synthesis (21, 22) . Alternatively, the lack of complementation may be due to physical differences between REV and ALSV polymerases. The SNV polymerase consists of a single polypeptide of about 70,000 daltons, intermediate in size between the two subunits of the ALSV polymerase (22) . Thus, if the polymerase molecule plays some structural role in the core, the significant difference in sizes may preclude the incorporation of SNV polymerase into BH-RSVa virions or formation of a functional enzyme-primer-70S RNA complex.
REVs cause acute disease in a wide variety of fowl, suggesting that they have an extremely broad host range among avian species. The ability to form BH-RSV(REV) pseudotypes could allow introduction of the RSV genome into cells not normally susceptible to ASV in higher titers than with UV-irradiated Sendai virus-mediated fusion (4), allowing study of whether the block of replication is at the membrane during penetration or whether it occurs at subsequent steps.
REV can now be included with VSV and the pheasant viruses as "unrelated" viruses that can supply a functional envelope glycoprotein for an ASV. The extent to which the ALSV and REV interact appears to be limited to the envelope glycoprotein since no complementation was detected for the products of two other ALSV genes required for virus replication. These results are quite similar to those obtained with the pheasant viruses, in which complementation by APV was observed for glycoprotein but not polymerase (3, 11, 12) .
